MyAverix Finance
US · Healthcare
Fagron NV (ARSUF)
Drug Manufacturers - Specialty & Generic
Fagron NV (ARSUF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ARSUF
Fagron NV (ARSUF) — FAQ
What is ARSUF's P/E ratio?
The price-to-earnings (P/E) ratio for Fagron NV (ARSUF) is 18.00 (data as of 2026-05-23).
Does Fagron NV pay a dividend?
Dividend yield is not available in the current snapshot for Fagron NV (ARSUF). Check the MyAverix Finance app for the latest dividend data.
What sector is Fagron NV in?
Fagron NV (ARSUF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is ARSUF listed on?
ARSUF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.